Clinical trial
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
NCT05673031 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
- Lead sponsor
- Alberta Health services
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2023
- Completion date
- January 1, 2027
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuroendocrine tumors (net)